As part of the GBS|CIDP Foundation International’s mission to provide education and support research, we offer research grants to qualified applicants. Through the generosity of these many individual contributors, to whom the Foundation is most grateful, we are able to offer this Research Grant Program. The GBS|CIDP Foundation International has worldwide representation, sharing resources with local support group chapters nationally and internationally.

Foundation interests include GBS, both demyelinating and axonal variants, Miller Fisher syndrome, CIDP, Multifocal Motor Neuropathy, and others. Research interests cover a broad range of subjects including development of methods to more rapidly diagnose these disorders, identification of mechanisms involved in the pathogenesis, development of more effective treatments to limit the disease process, prevent complications and reduce long-term adverse sequelae.  For additional information, please contact:  grants@gbs-cidp.org

GBS|CIDP Foundation International Discovery Award: The GBS|CIDP Foundation believes in supporting research on GBS, CIDP, and variants by funding grants for projects that contribute to the knowledge of, and towards an eventual cure for, GBS, CIDP, and variants. We invite all researchers to apply for this 2-year, $100k/year grant opportunity. Letters of Intent due: November 1.

Submit Letter of Intent:   https://www.gbs-cidp.org/research/letter-of-intent 

GBS|CIDP Foundation International Elevation Award: The GBS|CIDP Foundation believes in supporting research on GBS, CIDP, and variants by funding grants for projects that contribute to the knowledge of, and towards an eventual cure for, GBS, CIDP, and variants. We invite all researchers to apply for this 1-year, $50k/year grant opportunity. Letters of Intent due: November 1.

Submit Letter of Intent: https://www.gbs-cidp.org/research/letter-of-intent

GBS|CIDP Foundation International MMN Elevation Award: In 2022 the Foundation initiated fundraising efforts to support research specifically for better treatments and diagnosis of Multifocal Motor Neuropathy. As a result of these efforts, we are announcing the first ever Request for Applications for a MMN specific grant. We invite all researchers to apply for this 1-year, $50k/year grant opportunity.Letters of Intent due: November 1.

Submit Letter of Intent: https://www.gbs-cidp.org/research/letter-of-intent

GBS|CIDP Foundation International Benson Fellowship: The Benson Fellowship is a three-year fellowship that provides an opportunity for talented scientists to engage in peripheral nerve of study. The aim of the scheme is to provide funds (up to $150k per year for three years) to enable clinicians or non-clinical scientists in training or having recently completed training to engage in a substantial research project in the field of inflammatory neuropathy at a Centre or Centers of Excellence or an Institution approved by the committee. Preference will be given to candidates who intend to pursue a long-term career in this field. Letters of intent due: September 1, 2024

The next fellowship cycle begins January 2025

Submit Letter of Intent: https://www.gbs-cidp.org/research/benson-letter-of-intent/

DOD PRMRP: The Department of Defense maintains a Peer Reviewed Medical Research Program to support research across the full range of science and medicine, with an underlying goal of enhancing the health, care, and well-being of military Service members, Veterans, retirees, and their family members. Projects related to Peripheral Neuropathy are eligible to apply for funding through this program thanks to the partnership between the Foundation and key Congressional partners who recognize a relationship between GBS and Service members.

Submit: https://cdmrp.health.mil/funding/prmrp

The goal of this funding mechanism is to support promising early career investigators (MD or PhD) who are likely to continue a strong future career in peripheral neuropathy research.  These grants are intended for any basic, translational, or clinical research project on peripheral neuropathy, in order to improve understanding of disease mechanisms, diagnosis, or treatments. Fundable areas of research include: epidemiological or behavioral studies, clinical trials or clinical research studies, studies of disease mechanisms, development of new technologies, and health services and outcomes research.  Disease-related studies not directly involving humans or human tissue (including animal models) are also encouraged if the primary goal is translational, in support of the development of therapies, diagnostic tests, or other tools to prevent or mitigate neuropathy.

Applications open on June 1 and close September 14, 2023. The funding and award period start July 1, 2024 and the award ends June 30, 2026. To learn more and apply, click here. For reference, please see the

The goal of this funding mechanism is to support promising early career investigators (MD or PhD) who are likely to continue a strong future career in peripheral neuropathy research.  These grants are intended for any basic, translational, or clinical research project on peripheral neuropathy, in order to improve understanding of disease mechanisms, diagnosis, or treatments. Fundable areas of research include: epidemiological or behavioral studies, clinical trials or clinical research studies, studies of disease mechanisms, development of new technologies, and health services and outcomes research.  Disease-related studies not directly involving humans or human tissue (including animal models) are also encouraged if the primary goal is translational, in support of the development of therapies, diagnostic tests, or other tools to prevent or mitigate neuropathy.

Applications open on June 1 and close September 14, 2023. The funding and award period start July 1, 2024 and the award ends June 30, 2026. To learn more and apply, click here. Also attached for your reference is the RFA.

Hunter’s CMT4B3 Research Foundation will grant awards to principal investigators, physician residents, hospitals, universities and clinicians who are interested in studying CMT4B3. Our grants are intended to help researchers explore novel ideas and answer questions related to the clinical aspects, therapies and/or genetic causes of CMT4B3.

Research proposals will be carefully vetted by the Scientific Advisory Board. The Board evaluates each proposal based on the excellence of the investigator, the work plan and the environment, as well as the project’s ability to be translated into treatments for people with CMT4B3.  For more information on this opportunity, please click here.  Questions? Please contact Alessandra Bolino, bolino.alessandra@hsr.it  and  Robin Schultz, info@cmt4b3research.org.